Stability, blood partition, and pharmacokinetics of a new proton pump inhibitor, YJA-20379-8

Research Communications in Molecular Pathology and Pharmacology

Volumn 100, Issue 2, 1998, Pages 187-200

  Chung, Su Y ^a   Han, Kye S ^a   Chung, Young Kuk ^b   Chang, Man S ^b   Lee, Myung G ^a  

^a Seoul National University   (South Korea)

^b Yungjin Pharm Co Ltd   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

3 BUTYRYL 8 ETHOXY 4 (ALPHA METHYLBENZYLAMINO) 1,7 NAPHTHYRIDINE; PROTON PUMP INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; DRUG ABSORPTION; DRUG CLEARANCE; DRUG STABILITY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RABBIT; RAT; STOMACH BLOOD FLOW; STOMACH ULCER;

ADMINISTRATION, ORAL; ANIMALS; ANTI-ULCER AGENTS; AREA UNDER CURVE; BILE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG STABILITY; HALF-LIFE; INFUSIONS, INTRAVENOUS; MALE; NAPHTHYRIDINES; PROTON PUMPS; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION;

EID: 0031865337     PISSN: 10780297     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Chiou, W.L. (1978) Critical evaluation of potential error in pharmacokinetic studies using the linear trapezoidal rule method for the calculation of the area under the plasma level-time curve. J. Pharmacokinet. Biopharm., 6: 539-546.
2. Chiou W.L. (1979) New calculation method for mean apparent drug volume of distribution and application to rationale dosage regimens. J Pharm. Sci., 68: 1067-1069.
3. Chiou, W.L. (1980) New calculation method of mean total body clearance of drugs and its application to dosage regimens. J. Pharm. Sci., 69: 90-91.
4. Chung, S.Y. (1998) Pharmacokinetics of 3-butyryl-4-[5-(R)-(+)-methylbenzyl amino]-8-ethoxy-1,7-naphthyridine (YJA-20379-8), an antiulcer candidate, in rats and rabbits. M.S. Thesis. Seoul National University, Seoul, South Korea.
5. Eatman, F.B., Colburn, W.A., Boxenbaum, H.G., Posmanter, H.N., Weinfeld, R.E., Ronfeld, R., Weissman, L., Moore, J.D., Gibaldi, M., and Kaplan, S. A. (1977) Pharmacokinetics of diazepam following multiple dose oral administration to healthy human subjects. J. Pharmacokinet. Biopharm., 5: 481-494.
6. Gibaldi, M. and Perrier, D. (1982) Pharmacokinetics, 2nd edn, Marcel-Dekker, New York.
7. Kim, S.H., Choi, Y.M., Lee, M.G. (1993) Pharmacokinetics and pharmacodynamics of furosemide in protein-calorie malnutrition. J. Pharmacokinet. Biopharm., 21: 1-17.
8. Kim, S.H., Han, K.S., Choi, W.S., Chang, M.S. and Lee, M.G. (1997) Stability, blood partition, and pharmacokinetics of a new reversible proton pump inhibitor, YJA-20379-1. Res. Commun. Mol. Pathol. Pharmacol., 98: 77-84.
9. Lee, M.G., Lui, C.Y. and Chiou, W.L. (1986) Pharmacokinetics of drugs in blood V: Aberrant blood and plasma concentration profiles of methotrexate during intravenous infusion. Biopharm. Drug Dispos., 7: 487-494.
10. Shin, W.G., Lee, M.G., Lee, M.H. and Kim, N.D. (1992) Pharmacokinetics of drugs in blood VII: Unusual distribution and blood storage effect of vancomycin. Biopharm. Drug Dispos., 13: 305-310.
11. Yoon, W.H., Park, J.H., Lee, W.I., Lee, J.W., Shim, C.-K. and Lee, M.G. (1996) Stability and blood partition of YH439: a new hepatoprotective agent. Drug Stab., 1: 106-111.
12. Yoon, W.H., Yoo, J.K., Lee, J.W., Shim, C.-K. and Lee, M.G. (1998) Speicies differences in pharmacokinetic of a hepatoprotective agent, YH439, and its metabolites, M4, M5, and M7, after intravenous and oral administration to rats, rabbits, and dogs. Drug Metab. Disposit., 26: 152-163.